Editor: The Nov. 23 editorial about Roseland correctly highlights how continuing efforts can result in improvements in Santa Rosa’s most-needy quadrant ( “Santa Rosa attention to Roseland pays off” ).
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal Treatment-Resistant Bipolar Depression and Chronic Pain. - Designed to Help Address the Needs of Over 13 Million ...
The new operator's business model relies heavily on a federal arbitration process to settle billing disputes with private insurers, submitting between 60% and 70% of all patient visits to arbitration ...